Ignite Creation Date:
2025-12-24 @ 6:31 PM
Ignite Modification Date:
2025-12-24 @ 6:31 PM
Study NCT ID:
NCT03778957
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-10
First Post:
2018-11-28
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2018-11-28
First Submit QC Date:
None
Study First Post Date:
2018-12-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2024-08-09
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-10-09
Last Update Post Date:
2025-10-10
Last Update Post Date Type:
ESTIMATED